RxDoctor Payments Data

James Jackson, PA

Physician Assistant · Corpus Christi, TXNPI 1871648253

Payments from drug & device makers

$833in general payments, 2019–2025

Across 51 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$335
  • Johnson & Johnson$110
  • Lundbeck LLC$78
  • Neurocrine Biosciences, Inc.$64
  • Tris Pharma Inc$40
  • Idorsia Pharmaceuticals US Inc$38
  • plus $168 from 8 others

What the payments were for

  • Food & beverage$833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$833 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$72,479
Medicare patients
207
Services billed
1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole37$71,349
PerserisRisperidone13$32,470
FanaptIloperidone18$28,903
VraylarCariprazine Hcl15$21,722
TrintellixVortioxetine Hydrobromide25$20,982
BelsomraSuvorexant28$15,066
Divalproex Sodium241$14,004
Bupropion XlBupropion Hcl171$10,312
Memantine Hcl278$9,723
Oxcarbazepine132$9,352
Divalproex Sodium ErDivalproex Sodium166$8,118
Quetiapine Fumarate ErQuetiapine Fumarate56$7,059
Paliperidone ErPaliperidone30$6,334
Duloxetine Hcl231$5,568
Clonazepam517$5,181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$17$71,34937 claims
AbbVieVraylar$335$21,72215 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$32$20,98225 claims
MerckBelsomra$16$15,06628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →